Literature DB >> 15935149

The role of thioredoxin reductase activity in selenium-induced cytotoxicity.

Zbigniew Madeja1, Jolanta Sroka, Christina Nyström, Linda Björkhem-Bergman, Tomas Nordman, Anastasios Damdimopoulos, Ivan Nalvarte, Lennart C Eriksson, Giannis Spyrou, Jerker M Olsson, Mikael Björnstedt.   

Abstract

The selenoprotein thioredoxin reductase is a key enzyme in selenium metabolism, reducing selenium compounds and thereby providing selenide to synthesis of all selenoproteins. We evaluated the importance of active TrxR1 in selenium-induced cytotoxicity using transfected TrxR1 over-expressing stable Human Embryo Kidney (HEK-293) cells and modulation of activity by pretreatment with low concentration of selenite. Treatment with sodium selenite induced cytotoxity in a dose-dependent manner in both TrxR1 over-expressing and control cells. However, TrxR1 over-expressing cells, which were preincubated for 72h with 0.1 microM selenite, were significantly more resistant to selenite cytotoxicity than control cells. To demonstrate the early effects of selenite on behaviour of HEK-293 cells, we also investigated the influence of this compound on cell motility. We observed inhibition of cell motility by 50 microM selenite immediately after administration. Moreover, TrxR1 over-expressing cells preincubated with a low concentration of selenite were more resistant to the inhibitory effect of 50 microM selenite than those not preincubated. It was also observed that the TrxR over-expressing cells showed higher TrxR1 activity than control cells and the preincubation of over-expressing cells with 0.1 microM selenite induced further significant increase in the activity of TrxR1. On the other hand, we demonstrated that TrxR1 over-expressing cells showed decreased glutathione peroxidase activity compared to control cells. These data strongly suggest that TrxR1 may be a crucial enzyme responsible for cell resistance against selenium cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935149     DOI: 10.1016/j.bcp.2005.02.023

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  15 in total

1.  Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction.

Authors:  Robyn L Poerschke; Philip J Moos
Journal:  Biochem Pharmacol       Date:  2010-10-12       Impact factor: 5.858

2.  Selenoprotein P regulation by the glucocorticoid receptor.

Authors:  Colleen Rock; Philip J Moos
Journal:  Biometals       Date:  2009-12       Impact factor: 2.949

3.  Different Forms of Selenoprotein M Differentially Affect Aβ Aggregation and ROS Generation.

Authors:  Ping Chen; Ruo-Ran Wang; Xiao-Jie Ma; Qiong Liu; Jia-Zuan Ni
Journal:  Int J Mol Sci       Date:  2013-02-25       Impact factor: 5.923

4.  Nutrigenetics, nutrigenomics, and selenium.

Authors:  Lynnette R Ferguson; Nishi Karunasinghe
Journal:  Front Genet       Date:  2011-04-25       Impact factor: 4.599

Review 5.  Encapsulated nanoepigallocatechin-3-gallate and elemental selenium nanoparticles as paradigms for nanochemoprevention.

Authors:  Dongxu Wang; Ethan Will Taylor; Yijun Wang; Xiaochun Wan; Jinsong Zhang
Journal:  Int J Nanomedicine       Date:  2012-03-29

6.  The expression and activity of thioredoxin reductase 1 splice variants v1 and v2 regulate the expression of genes associated with differentiation and adhesion.

Authors:  Ivan Nalvarte; Anastasios E Damdimopoulos; Joëlle Rüegg; Giannis Spyrou
Journal:  Biosci Rep       Date:  2015-10-13       Impact factor: 3.840

7.  Bioaccumulation and toxicity of selenium compounds in the green alga Scenedesmus quadricauda.

Authors:  Dása Umysová; Milada Vítová; Irena Dousková; Katerina Bisová; Monika Hlavová; Mária Cízková; Jirí Machát; Jirí Doucha; Vilém Zachleder
Journal:  BMC Plant Biol       Date:  2009-05-15       Impact factor: 4.215

8.  Variation in drug sensitivity of malignant mesothelioma cell lines with substantial effects of selenite and bortezomib, highlights need for individualized therapy.

Authors:  Adam Szulkin; Gustav Nilsonne; Filip Mundt; Agata M Wasik; Pega Souri; Anders Hjerpe; Katalin Dobra
Journal:  PLoS One       Date:  2013-06-20       Impact factor: 3.240

9.  Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase.

Authors:  Chaoran Liu; Zhong Liu; Meng Li; Xiaoling Li; Yum-Shing Wong; Sai-Ming Ngai; Wenjie Zheng; Yibo Zhang; Tianfeng Chen
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

10.  Gene expression changes for antioxidants pathways in the mouse cochlea: relations to age-related hearing deficits.

Authors:  Sherif F Tadros; Mary D'Souza; Xiaoxia Zhu; Robert D Frisina
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.